HOUSTON, Nov. 1, 2013 /PRNewswire/ -- TexCom, Inc. (OTC Pink: TEXC) (the "Company" or "TexCom"), an environmental services company serving the oil and gas industry, today announced financial results for the third quarter of 2013. Financial Highlights for the third quarter 2013 compared to the third quarter 2012:

    --  Revenues totaled $4.15 million, increasing 57% from $2.65 million.
    --  Gross profit margin held steady at 45%.
    --  Operating income increased 45% to $1.05 million from $721,000.
    --  Net income available to shareholders decreased from $2.28 million to
        $2.05 million.  In both years, the company revalued its deferred income        tax assets resulting from its net operating loss carryforwards (NOLs)        and other book-to-tax differences.  As a result, the company recognized       $1.31 million of income tax benefit in the third quarter of 2013,
        compared to a benefit of $1.96 million for the third quarter of 2012.
    --  Earnings per share on a fully diluted basis were unchanged at $0.03.

Financial Highlights for the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012:

    --  Revenues totaled $11.8 million, increasing 33% from $8.86 million.
    --  Gross profit margin held steady at 50%.
    --  Operating income increased 44% to $4.25 million from $2.95 million.
    --  Net income available to shareholders rose 6% to $3.62 million from $3.43
        million.  In both years, the company revalued its deferred income tax
        asset resulting from its net operating loss carryforwards (NOLs) and
        other book-to-tax differences.  As a result, the company recognized
        $340,000 of income tax benefit in the first nine months of 2013,
        compared to a benefit of $1.96 million for the first nine months of
        2012.
    --  Earnings per share on a fully diluted basis were unchanged at $0.05.

Prior to the third quarter of 2012, the Company valued its net operating loss carryforwards (NOLs) at zero due to the uncertainty of generating future income to utilize the NOLs. With the substantial improvement in operations, the Company revalued the NOLs and recorded the future benefit as an asset, and has been recognizing income tax expense since the third quarter of 2012. In the third quarter of 2013, the Company again revalued certain deferred income tax assets including the NOLs and other book-to-tax differences and increased its estimate of their value by approximately $1.6 million.

"While third quarter 2013 results were substantially improved over the third quarter 2012, operating income and net income were significantly less than the results achieved in the first two quarters of 2013. Results at MB Environmental Services, LLC were reduced due to lower revenues and increased property maintenance costs incurred during the quarter. Results at Eagle Ford Environmental Services, LLC were reduced due to lower revenues as the facility was shut down for several periods to allow the completion of the second disposal well. The second well is expected to be operational within the next week. However, TexCom Environmental Services, LLC generated better than expected revenues and operating income," stated Bob May, CEO and President.

So even with all the temporary trouble, they still made profit. Now all problems are fixed and they have new well that is already working. Next quarter should be even better. Shares at this price are cheap. Will check back on this stock sometime next year to see if I'm right. Happy stock hunting.

http://www.4-traders.com/TEXCOM-INC-158512/news/Texcom-Inc--TexCom-Announces-Results-for-Third-Quarter-of-2013-17420176/

ohn Turanin, Vice President and General Manager, DosePro Technology, at Zogenix, said, "Through our co-marketing agreement with Battelle, we have expanded awareness of the DosePro needle-free drug delivery system. Battelle has proved to be a strong technical and business development ally and interest in the DosePro technology from biopharmaceutical companies has significantly increased because of Battelle's support. We are pleased with our progress and continue to believe there is significant potential to out-license DosePro for the delivery of biologics. Our new 5-year agreement with Battelle underscores both companies' commitment to achieving this goal, which includes executing on near-term and future opportunities."

"The DosePro technology offers the opportunity to solve major challenges in self-administration of important biologic therapies," added William Dunlevy, Vice President and General Manager, Process and Product Development at Battelle. "DosePro's advantages in delivery of highly viscous formulations and its attributes which support protein stability are unmatched by standard autoinjector technology, and offer valuable options to our biopharmaceutical clients."